115378-50-2

Upstream product

• 115378-43-3 2-<(4R,5R)-4,5-bis(methoxymethyl)-1,3-dioxalan-2-yl>-2-methyl-5-hexen-3-one 
• 115378-47-7 (R)-3-Benzyloxy-4-((4R,5R)-4,5-bis-methoxymethyl-[1,3]dioxolan-2-yl)-4-methyl-pentan-1-ol 
• 115378-46-6 (R)-3-Benzyloxy-4-((4R,5R)-4,5-bis-methoxymethyl-[1,3]dioxolan-2-yl)-4-methyl-pentanal 
• 115378-48-8 (4R,5R)-2-((R)-2,4-Bis-benzyloxy-1,1-dimethyl-butyl)-4,5-bis-methoxymethyl-[1,3]dioxolane 
• 115378-44-4 (4R,5R)-4,5-bis(methoxymethyl)-2-<(R)-2-hydroxy-1,1-dimethyl-4-pentenyl>-1,3-dioxolane 
• 115378-45-5 (4R,5R)-2-((R)-2-Benzyloxy-1,1-dimethyl-pent-4-enyl)-4,5-bis-methoxymethyl-[1,3]dioxolane 

Downstream Products

• 115378-51-3 (R)-6,8-bis(benzyloxy)-5,5-dimethyl-1-octen-4-one 

Relevant academic research and scientific papers

A Formal Synthesis of Aplasmomycin. Assembly of the C3-C17 Segment Based on Remote Controlled Asymmetric Reductions

The C3-C17 segment of a boron containig ionophoric antibiotic aplasmomycin (1), the key intermediate in Corey's total synthesis of 1, was stereoselectively synthesized in an optically active form through remote controlled asymmetric reductions.